2025. Clinical Efficacy of the Human Tyrosinase Inhibitor Thiamidol (isobutylamido thiazolyl resorcinol) in Melasma. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s544. DOI:https://doi.org/10.25251/skin.10.supp.544.